Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo .

MLA

Pan, Tianhong, et al. “Cabozantinib Reverses Renal Cell Carcinoma-Mediated Osteoblast Inhibition in Three-Dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo .” Molecular Cancer Therapeutics, vol. 19, no. 6, June 2020, pp. 1266–78. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-19-0174.

APA

Pan, T., Martinez, M., Hubka, K. M., Song, J. H., Lin, S.-C., Yu, G., Lee, Y.-C., Gallick, G. E., Tu, S.-M., Harrington, D. A., Farach-Carson, M. C., Lin, S.-H., & Satcher, R. L. (2020). Cabozantinib Reverses Renal Cell Carcinoma-mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo . Molecular Cancer Therapeutics, 19(6), 1266–1278. https://doi.org/10.1158/1535-7163.MCT-19-0174

Chicago

Pan, Tianhong, Mariane Martinez, Kelsea M Hubka, Jian H Song, Song-Chang Lin, Guoyu Yu, Yu-Chen Lee, et al. 2020. “Cabozantinib Reverses Renal Cell Carcinoma-Mediated Osteoblast Inhibition in Three-Dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo .” Molecular Cancer Therapeutics 19 (6): 1266–78. doi:10.1158/1535-7163.MCT-19-0174.